ASCO/IDSA Webinar: The COVID-19 Vaccine & Patients with Cancer

On December 17 at 3:00 PM Eastern, the American Society of Clinical Oncology and the Infectious Diseases Society of America hosted a panel discussion on the use of the COVID-19 vaccines for cancer patients. The panel included experts in infectious diseases and oncology, and discussed available data on vaccine safety and efficacy, use of vaccines in immunocompromised patients, and management of adverse reactions.

Introductions

• Dana S. Wollins, DrPH, MGC
  Vice President, Clinical Affairs & Practice Guidelines, IDSA

Moderator

• Stephen S. Grubbs, MD, FASCO
  Vice President, Clinical Affairs
  American Society of Clinical Oncology (ASCO)

Featured Panelists

• Joshua A. Hill
  MD Assistant Professor, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
  Assistant Professor, Division of Allergy and Infectious Diseases, University of Washington

• Michael G. Ison, MD, MS, FIDSA, FAST
  Professor, Divisions of Infectious Diseases and Organ Transplantation
  Northwestern University Feinberg School of Medicine
  Medical Director, Transplant & Immunocompromised Host Infectious Diseases Service
  Director, Center for Clinical Research
  Northwestern University Clinical and Translational Sciences Institute

• Gary H. Lyman, MD, MPH (Biostatistics), FASCO, FACP, FRCP
  Professor, Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Research Center
  Senior Lead, Healthcare Quality and Policy, Hutchinson Institute for Cancer Outcomes Research
  Professor of Medicine, Public Health and Pharmacy, University of Washington School of Medicine
  Executive Officer, SWOG Cancer Research Network